As I’ve continued to reflect on recent events, and what they mean to us as individuals and as an organization, I wanted to share some thoughts about changes that we will be making at Gladstone.
Over the last week, I’ve met with many of our Black colleagues to hear their concerns and gather feedback about their experiences at Gladstone. I am so grateful to each of them for their time, thoughtful consideration, and willingness to share, which I believe has already been invaluable in shaping our way forward.
One of the aims of our strategic plan is to “ensure Gladstone provides a diverse and inclusive workplace environment that empowers every member of the organization to fully contribute to the mission.” It has become increasingly clear that we have work to do here and that it will require long-term and sustained commitment to make a meaningful difference. It is also clear that we must go beyond being “intolerant” of racism or any kind of discrimination, to being more actively anti-racist and anti-discrimination in all our policies and actions.
While we must be thoughtful and very intentional on the long-term efforts, these are the first steps we are taking at Gladstone to increase diversity, improve our institute culture, and move forward:
We know we have a long way to go, but Gladstone is committed to taking the next steps. We will certainly not do everything perfectly, but we are willing to learn and grow as individuals and as an organization. We will continue to listen to open and honest feedback from our employees and peers.
Sincerely,
Deepak Srivastava
President, Gladstone Institutes
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Explore CareersThe San Francisco Business Times has named Srivastava as one of the Most Admired CEOs among Bay Area businesses and nonprofits. The cardiologist and stem cell pioneer has served in the top leadership role at Gladstone Institutes since 2018.
Awards Institutional News News Release Congenital Heart Disease Cardiovascular Disease Srivastava LabCelebrating 25 years of neurological disease research at Gladstone
History Institutional News News Release Neurological DiseaseThis distinction recognizes his and the institute’s pioneering blend of genomics and immunology toward the design and improvement of cancer immunotherapy
Institutional News Genomic Immunology Marson Lab